Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes

Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes

Sunghan Yim,1 Jeesun Lee,2 Hae Jo,2 Jeff Scholten,1 Ryan Willingham,3 Jim Nicoll,3 Sudhir M Baswan4 1Analytical Sciences R&D, Amway Corporation, Ada, MI, USA; 2Asia Innovation Center, Global Discovery R&D, Amway Corporation, Seoul, South Korea; 3Zen-Bio, Inc., Research Triangle Park,...

Full description

Bibliographic Details
Main Authors: Yim S, Lee J, Jo H, Scholten J, Willingham R, Nicoll J, Baswan SM
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
cellular dna photodamage
chrysanthemum morifolium extract
ascorbic acid-2-glucoside (aa2g)
dna damage
cyclobutane pyrimidine dimers (cpd)
dark cpd
melanocytes
uv radiation
Online Access:https://www.dovepress.com/chrysanthemum-morifolium-extract-and-ascorbic-acid-2-glucoside-aa2g-bl-peer-reviewed-article-CCID

Internet

https://www.dovepress.com/chrysanthemum-morifolium-extract-and-ascorbic-acid-2-glucoside-aa2g-bl-peer-reviewed-article-CCID

Similar Items